Lin R, Zhu X, Zhang Z, Kang M, Xia Q
Department of Thoracic Surgery, Affiliated Children's Hospital, Zhejiang University, Hangzhou 310003, China.
Chin Med J (Engl). 2001 Nov;114(11):1184-8.
To investigate the effectiveness of pinacidil, an opener of ATP-sensitive K+ channels, in protecting the myocardium of immature rabbit hearts from ischemic reperfusion injury.
Rabbit hearts underwent 30 min of global normothermic ischemia followed by 30 min of reperfusion on the modified Langendorff apparatus. Fifty-two isolated hearts of 3-4 week-old immature rabbits were divided into 4 groups randomly. During ischemia, 3 different cardioplegic solutions were administered intermittently by infusion every 15 min (20-25 ml each time in all groups). Group 1: control group (n = 13); group 2: Krebs-Henseleit (K-H) solution with potassium (16 mmol/L) (n = 13); group 3: K-H solution with potassium (16 mmol/L) and pinacidil (50 mumol/L) (n = 13); group 4: K-H solution with potassium (16 mmol/L), pinacidil (50 mumol/L) and glibenclamide (10 mumol/L) (n = 13). The pre-ischemic and post-ischemic myocardial functions were assessed by the percentage recovery of the left ventricular developed pressure (LVDP); the left ventricular end-diastolic pressure (LVEDP); both the positive peak and negative peaks of the first derivative of the left ventricular pressures (+/- dp/dtmax); coronary flow; the level of creatine kinase (CK), lactic dehydrogenase (LDH) and aspartate transcarbamoylase (AST) in coronary sinus venous effluent; and by myocardial ultrastructural changes.
Before myocardial ischemia, there were no significant differences among the four groups in any of the parameters mentioned above. Post-ischemic recovery of LVDP, LVEDP, +/- dp/dtmax, coronary flow, the level of CK, LDH and AST, and myocardial ultrastructural changes were better in group 3 than those in the three other groups.
As a new and effective composition, pinacidil can significantly improve myocardial protection from cardioplegia for immature rabbit hearts.
研究ATP敏感性钾通道开放剂吡那地尔对未成熟兔心脏心肌缺血再灌注损伤的保护作用。
兔心脏在改良Langendorff装置上进行30分钟全心常温缺血,随后再灌注30分钟。将52只3 - 4周龄未成熟兔的离体心脏随机分为4组。在缺血期间,每15分钟间歇输注3种不同的心脏停搏液(每组每次20 - 25毫升)。第1组:对照组(n = 13);第2组:含钾(16 mmol/L)的Krebs - Henseleit(K - H)溶液(n = 13);第3组:含钾(16 mmol/L)的K - H溶液加吡那地尔(50 μmol/L)(n = 13);第4组:含钾(16 mmol/L)的K - H溶液、吡那地尔(50 μmol/L)加格列本脲(10 μmol/L)(n = 13)。通过左心室舒张末压(LVDP)恢复百分比、左心室舒张末压(LVEDP)、左心室压力一阶导数的正峰和负峰(± dp/dtmax)、冠状动脉血流量、冠状窦静脉流出液中肌酸激酶(CK)、乳酸脱氢酶(LDH)和天冬氨酸转氨甲酰酶(AST)水平以及心肌超微结构变化来评估缺血前后的心肌功能。
心肌缺血前,上述各项参数在四组之间均无显著差异。缺血后,第3组的LVDP、LVEDP、± dp/dtmax、冠状动脉血流量、CK、LDH和AST水平以及心肌超微结构变化的恢复情况均优于其他三组。
作为一种新型有效成分,吡那地尔可显著改善未成熟兔心脏心肌停搏液的心肌保护作用。